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Abstract We investigated the in vivo effects of a novel
aquaporin 4 (AQP4) inhibitor 2-(nicotinamide)-1,3,4-thia-
diazole, TGN-020, in a mouse model of focal cerebral
ischemia using 7.0-T magnetic resonance imaging (MRI).
Pretreatment with TGN-020 signiﬁcantly reduced brain
edema associated with brain ischemia, as reﬂected by per-
centage of brain swelling volume (%BSV), 12.1 ± 6.3% in
the treated group, compared to (20.8 ± 5.9%) in the control
group (p\0.05), and in the size of cortical infarction as
reﬂected by the percentage of hemispheric lesion volume
(%HLV), 20.0 ± 7.6% in the treated group, compared to
30.0 ± 9.1% in the control group (p\0.05). The study
indicated the potential pharmacological use of AQP4
inhibition in reducing brain edema associated with focal
ischemia.
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Introduction
Cerebral edema is one of the well recognized potentially
serious complications of cerebral ischemia [1]. While
edema is believed to be an important factor of the high
morbidity and mortality of large territory ischemic strokes,
clinical options for treating cerebral edema remain limited
[2]. Accumulated evidence now indicates that aquaporin 4
(AQP4), the most abundant water channel in brain, plays
an essential role in the pathogenesis of cerebral edema [3].
AQP4 belongs to the aquaporin family of transmembrane
water and water/glycerol transporters [4] and is found in
high concentrations in mammalian astrocytes, particularly
intheperiventricularregionandsubpialendfeet[5].Genetic
deletionofAQP4amelioratesbrainswellingduetoischemia
[6]. Transgenic mice lacking the dystrophin-associated
protein complex, by which end-foot pooled AQP4 is
anchored [7], show less severe ischemic edema compared to
wild-type mice [8]. Genetic deletion of a-syntrophin, which
is a member of the dystrophin-associated protein complex,
also reduces ischemic edema [9, 10].
Recently, we identiﬁed several chemical structures with
AQP4 inhibitory effect [11, 12]. Using an in vitro bioassay,
2-(nicotinamide)-1,3,4-thiadiazole, TGN-020, was found to
be the most potent AQP4 inhibitor among the agents
studied [13]. In this study, we investigated the in vivo
effects of TGN-020 on cerebral edema in a mouse model of
focal cerebral ischemia using 7.0-T magnetic resonance
imaging (MRI) in an attempt to ﬁnd new pharmacological
agents effective for treating ischemic cerebral edema.
Materials and methods
Animal preparation
All animal experiments were conducted in accordance with
the National Institutes of Health guidelines for the care and
use of animals in research [14], and used protocols
approved by the University of Niigata Animal Care and
Use Committee. Twenty-four adult male mice, C57/BL6
(weight 23–28 g) were maintained under standard labora-
tory conditions with a 12 h/12 h light/dark cycle. Food and
water were available ad libitum, except for 10 h prior to
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vent hyperglycemia.
Mice were anesthetized with 1–1.2% halothane in 30%
oxygen and 70% nitrous oxide administered through a face
mask, with the animals breathing spontaneously. Rectal
temperature was maintained at 37 ± 0.5C using a tempera-
turecontrolunitandheatingpadduringtheanesthesiaperiod.
Oxygen saturation (SpO2) was monitored throughout the
operation procedure using a pulse oxymeter Mouse Ox
(STARR Life Sciences Co, Oakmont, PA, USA) with probe
placement on the left thigh. Regional cerebral blood ﬂow
(rCBF)wasmeasuredcontinuouslystartingimmediatelyprior
to and throughout the 120-min interval of induced focal
ischemia using laser-Doppler ﬂowmetry (ALF21, Advance
Co.,Tokyo,Japan).TheDopplerprobewasafﬁxedtotheskull
1 mm posterior and 6 mm laterally to the Bregma. Study
animals received a single injection, intra-peritoneally, of
TGN-020sodiumsalt,200 mg/kg,dissolvedin0.1 mlnormal
saline, 15 min before induction of ischemia. Control animals
received an identical volume of normal saline, intra-perito-
neally. An additional seven mice underwent sham operation
where only isolation of the carotid artery was performed.
Transient focal cerebral ischemia was induced using a
modiﬁed version of the procedure described by Yang et al.
[15]. The right middle cerebral artery (MCA) was occluded
by introducing a 6-0 silicone-coated monoﬁlament into the
internal carotid artery to a point 6 mm distal to the internal
carotid artery and pterygopalatine arterial bifurcation. Suc-
cess of the MCA occlusion was conﬁrmed in mice fulﬁlling
the following three conditions: a greater than 93% of SpO2
throughout the operation procedure; a greater than 80%
decrease in rCBF (CBF%) at 15–20 min following the
ischemic insult relative to pre-ischemia level; and a neuro-
logical deﬁcit score of 2 or greater at 30 min post-ischemia
after allowing the mouse to regain consciousness. Neuro-
logicaldeﬁcitscoringwasdoneusingthecriteriaestablished
by Amiry-Moghaddam et al. [9]: normal motor function, 0;
ﬂexionofthetorsoandcontralateralforelimbuponliftingthe
animal by the tail, 1; circling to the contralateral side but
normal posture at rest, 2; leaning to the contralateral side at
rest, 3; no spontaneous motor activity, 4. The ﬁlament was
removed under anesthesia 2 h after induction of ischemia.
MRI
MRI studies were carried out 24 h after induction of
ischemia on a 15-cm bore, 7-T horizontal magnet (Magnex
Scientiﬁc, Abingdon, UK) equipped with a Varian Unity-
INOVA-300 system (Varian Inc, Palo Alto, CA, USA) that
had an actively shielded gradient. Anesthetized mice
(1–1.2% halothane in 30% oxygen and 70% nitrous oxide
administered through a face mask), breathing spontane-
ously, were positioned on their back in a tailor-made
Plexiglas stereotaxic holder. The head was immobilized
using ear and tooth bars. Rectal temperature was main-
tained at 37 ± 0.5C using a specially designed tempera-
ture controlling system.
T2-weighted images were acquired using a fast-spin echo
(FSE) sequence with ETE/TR = 80/2,000 ms; echo train, 4;
ﬁeld of view, 20 9 20 mm; matrix size, 256 9 256; and
slice thickness, 1 mm without gap. 12 contagious slices
were obtained to cover the entire brain volume.
Image and statistical analysis
Imaging data were transferred to a workstation (Blade1000,
Sun Microsystems, Milpitas, CA, USA) and analyzed using
MR Vision (MR Vision Co., Menlo Park, CA, USA).
Quantitativeindicesofedema andinfarctionwereexpressed
as percentage of brain swelling volume (%BSV) and hemi-
spheric lesion volume (%HLV), respectively, as described
by Gerriets et al. [16]. To correct the overestimation of
infarcted area by cerebral edema, the relative size of the
infarct area (% hemispheric lesion volume = %HLV) was
derived as follows:
% HLV ¼ Contralateral area   total ipsilateral area ð ½ f
 infarct areaÞ = contralateral cortex ð
þcontralateral striatumÞg   100:
Corresponding volumes were then calculated for the total
set of slices. Quantiﬁcation of the effect of cerebral swelling
was then expressed as the volume increase of the ipsilateral
hemisphere (% brain swelling volume = %BSV) based on
the following equation:
% BSV ¼ total ipsilateral area/contralateral area ðÞ   100:
The size of the corresponding area on each imaging slice
was quantiﬁed on the FSE image semi-automatically.
Numerical data were subsequently subjected to two-way
ANOVA with Fisher’s post hoc test; p less than 0.05 was
regarded as being statistically signiﬁcant.
Results
Physiological parameters and rCBF following ischemia
induction monitored by laser-Doppler ﬂowmetry were vir-
tually identical between control and TGN-020 treated groups
(Table 1). Three out of 17 mice did not ﬁt the inclusion
criteria (one mouse exhibited respiratory distress with an
SpO2 under 94%, while the other two did not meet the
minimum neurological deﬁcit score). Thus, seven animals
each of the vehicle and TGN-020 administered groups were
analyzed by MRI. All mice meeting the inclusion criteria
survived to the end of the MRI measurements.
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aresummarizedinFig. 2.The%BSVoftheTGN-020group
(12.1 ± 6.3%) was signiﬁcantly smaller than that of the
control group (20.8 ± 5.9%). Likewise, the %HLV of cor-
tex in the TGN-020 group (20.0 ± 7.6%) was also signiﬁ-
cantly smaller than that in the control group (30.0 ± 9.1%).
The basal ganglia infarction volume in treated and control
animals showed essentially no difference (Table 1). All
sham operated mice showed no apparent infarction area.
Discussion
The current study convincingly demonstrated that pre-
treatment with the AQP4 inhibitor TGN-020 signiﬁcantly
reduced the volume of brain edema associated with
ischemic injury. Ischemic edema is believed to be initiated
by inﬂux of Na
? associated with energy failure. Higher
osmolarity conditions create the driving force for water
inﬂux into cells, resulting in ionic edema [17]. This early
edema phase, so-called cytotoxic edema, is believed to last
several hours before bulk leakage of water into the brain
ensues, producing so-called vasogenic edema [18]. AQP4
is believed to play a signiﬁcant role in the actual water ﬂux
in both processes.
Flux through AQP4 is bidirectional and purely depen-
dent on osmolarity differences between the two spaces
connected by AQP4. Theoretically, pretreatment with an
AQP4 inhibitor can block water movement through these
water channels, thereby reducing the main water inﬂux
associated with inﬂux of Na
?, and delaying the develop-
ment of full-ﬂedged ionic edema. Although speculative,
halting the early process mediating brain edema, may
interrupt the subsequent cascade of events that lead to
further edema such as astrocytic process swelling, up-reg-
ulation of astrocytic volume-regulated anion channel
(VRAC) [19, 20], or further inﬂux of osmotically active
ions [18]. An interesting observation in this study was the
differential effect on infarct size by AQP4 inhibition.
Whereas TGN-020 signiﬁcantly reduced the cortical infarct
volume (p\0.05), it essentially had no effect on basal
ganglia infarct volume. While entirely conjectural, the
pathophysiologic mechanism underlying the observations
may reﬂect the differential distribution of AQP4 channels
in perivascular regions and cortical surfaces [3]. It is
plausible that the difference in infarction volume between
control and AQP4 treated animals denoted the effect of
edema on infarction, and, therefore, represented potentially
salvageable tissue by AQP4 inhibition. On the other hand,
the similar %HLV, reﬂecting infarct volume for basal
ganglia in both control and treated animals as well as for
cortex in treated animals only, likely represented the direct
result of ischemia.
Table 1 Summary of physiological parameters and results
SpO2 (%) Core temperature (C) CBF% %HLV %BSV
Pre During Post Pre During Post Total BG Cortex
Sham (n = 7)
Mean 97.4 97.2 37.4 37.0
SD 0.6 0.4 0.2 0.2
TGN-020 (n = 7)
Mean 97.2 96.6 97.6 36.9 37.2 37.0 11.6 48.8 18.8 30.0 20.8
SD 0.9 1.2 0.7 0.2 0.2 0.2 5.2 11.5 3.5 9.1 5.9
Vehicle (n = 7)
Mean 97.3 96.9 97.4 37.0 37.0 37.1 12.8 37.9 17.8 20.0 12.1
SD 0.4 0.7 1.1 0.3 0.3 0.2 3.4 10.6 4.9 7.6 6.3
Statistical signiﬁcance (TGN vs. vehicle) NS NS NS NS NS NS NS p = 0.037 NS p = 0.024 p = 0.011
pre pre-ischemia, during during ischemia, post following recirculation
Fig. 1 Representative FSE (TR = 2,000 ms, ETE = 80 ms) images
of control (No. 3) and TGN-020 treated mouse (No. 5). Note that
midline shift due to ischemic brain swelling is much less conspicuous
in the TGN-020 treated mouse
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123In conclusion, we assessed the in vivo effect of a novel
AQP4 inhibitor, TGN-020. Pretreatment with TGN-020
signiﬁcantly reduced the severity of brain edema associated
with brain ischemia. Further studies that better simulate
clinical treatment conditions are essential. Nevertheless,
AQP4 inhibition is a novel approach in reducing cerebral
edema, and appears promising for the development of a
unique class of pharmacologic agents effective in the
clinical treatment of brain ischemia.
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